Greenitio, a Singapore-based startup specializing in sustainable biopolymers, has raised US$1.5 million in Seed funding to accelerate its commercial readiness, focusing on replacing harmful synthetic ingredients in cosmetics and specialty chemicals.
Target Company Overview
Greenitio is a Singapore-based startup founded in 2021 that specializes in the development of functional biopolymers derived from fungal chitosan. The company's innovative approach allows it to replace synthetic and petrochemical ingredients commonly used in the cosmetics and specialty chemicals industries with sustainable alternatives. Through its patented green chemistry process, Greenitio produces high-performance, bio-based polymers that offer functional benefits such as film formation, deep moisturization, and enhanced active ingredient delivery.
Greenitio's flagship product lines, including Chitosola™, Chitobe™, and Chitobela™, are multifunctional biopolymers that cater to skin, sun, and hair care applications. These products have been registered in the International Nomenclature of Cosmetic Ingredients (INCI) and the Inventory of Existing Cosmetic Ingredients in China (IECIC), showcasing their regulatory compliance and readiness for market entry.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The cosmetics and specialty chemicals industries are undergoing a significant transformation as consumers and brands increasingly seek sustainable and eco-friendly products. In Singapore, as well as across the globe, there is
Similar Deals
Pace Ventures → ChemFinity Technologies
2025
TGFS Technologiegründerfonds Sachsen, GIMIC Ventures, bm-t, Chemovator → Zepta
2025
World Fund, Azolla Ventures → Net Zero Nitrogen (NZN)
2025
SGInnovate
invested in
Greenitio
in 2025
in a Seed Stage deal
Disclosed details
Transaction Size: $2M